TCL Archive High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer January 25, 2008
TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive In Brief: Shingleton “Unretires” As Director Of Duke Center; O’Brien Interim Head At USC When Hammond Leave July 24, 1981
TCL Archive Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint May 31, 2013
TCL Archive In Brief: NCI Names Rice To Head Frederick Center; NIAID Appoints Killen DAIDS Director April 22, 1994